openPR Logo
Press release

mRNA Vaccine Market just Published Research Report

05-31-2020 02:36 PM CET | Health & Medicine

Press release from: QY Research, Inc

mRNA Vaccine Market Report Top-Companies Offerings And Market By End-User Segments Forecasted Till 2026|Moderna Therapeutics, CureVac, Translate Bio

The global mRNA Vaccine market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global mRNA Vaccine market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global market. The authors of the report profile leading companies of the global mRNA Vaccine market, Also the details about important activities of leading players in the competitive landscape.

Some of the Important Key player operating in the Report are: , Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1593796/global-mrna-vaccine-market

The report predicts the size of the global mRNA Vaccine market in terms of value and volume for the forecast period 2020-2026. As per the analysis provided in the report, the global mRNA Vaccine market is expected to rise at a CAGR of xx % between 2020 and 2026 to reach a valuation of US$ xx million/billion by the end of 2026. In 2020, the global mRNA Vaccine market attained a valuation of US$ XX million/billion. The market researchers deeply analyze the global mRNA Vaccine industry landscape and the future prospects it is anticipated to create

Segmental Analysis

The report has classified the global mRNA Vaccine industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the mRNA Vaccine manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall mRNA Vaccine industry.

Global mRNA Vaccine Market Segment By Type:

mRNAStandardization Of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, Infection Prevention MRNA Vaccine

Global mRNA Vaccine Market Segment By Application:

Standardization Of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, Infection Prevention MRNA Vaccine

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global mRNA Vaccine industry. In order to fulfill the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global mRNA Vaccine market include: , Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology

Key questions answered in the report:

What is the growth potential of the mRNA Vaccine market?
Which product segment will grab a lion's share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the mRNA Vaccine industry in the years to come?
What are the key challenges that the global mRNA Vaccine market may face in the future?
Which are the leading companies in the global mRNA Vaccine market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global mRNA Vaccine market
Enquire for Customization in the Report: https://www.qyresearch.com/customize-request/form/1593796/global-mrna-vaccine-market

Table of Contents

Table of Contents 1 mRNA Vaccine Market Overview
1.1 mRNA Vaccine Product Overview
1.2 mRNA Vaccine Market Segment by Type
1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Global mRNA Vaccine Market Size by Type (2015-2026)
1.3.1 Global mRNA Vaccine Market Size Overview by Type (2015-2026)
1.3.2 Global mRNA Vaccine Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global mRNA Vaccine Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global mRNA Vaccine Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global mRNA Vaccine Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global mRNA Vaccine Market Size Forecast by Type (2021-2026)
1.3.3.1 Global mRNA Vaccine Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global mRNA Vaccine Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global mRNA Vaccine Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America mRNA Vaccine Sales Breakdown by Type (2015-2026)
1.4.2 Europe mRNA Vaccine Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific mRNA Vaccine Sales Breakdown by Type (2015-2026)
1.4.4 Latin America mRNA Vaccine Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa mRNA Vaccine Sales Breakdown by Type (2015-2026) 2 Global mRNA Vaccine Market Competition by Company
2.1 Global Top Players by mRNA Vaccine Sales (2015-2020)
2.2 Global Top Players by mRNA Vaccine Revenue (2015-2020)
2.3 Global Top Players mRNA Vaccine Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers mRNA Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 mRNA Vaccine Market Competitive Situation and Trends
2.5.1 mRNA Vaccine Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by mRNA Vaccine Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine as of 2019)
2.7 Date of Key Manufacturers Enter into mRNA Vaccine Market
2.8 Key Manufacturers mRNA Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion 3 Global mRNA Vaccine Status and Outlook by Region (2015-2026)
3.1 Global mRNA Vaccine Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global mRNA Vaccine Market Size Market Share by Region (2015-2020)
3.2.1 Global mRNA Vaccine Sales Market Share by Region (2015-2020)
3.2.2 Global mRNA Vaccine Revenue Market Share by Region (2015-2020)
3.2.3 Global mRNA Vaccine Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global mRNA Vaccine Market Size Market Share by Region (2021-2026)
3.3.1 Global mRNA Vaccine Sales Market Share by Region (2021-2026)
3.3.2 Global mRNA Vaccine Revenue Market Share by Region (2021-2026)
3.3.3 Global mRNA Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America mRNA Vaccine Market Size YoY Growth (2015-2026)
3.4.1 North America mRNA Vaccine Revenue YoY Growth (2015-2026)
3.4.2 North America mRNA Vaccine Sales YoY Growth (2015-2026)
3.5 Asia-Pacific mRNA Vaccine Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific mRNA Vaccine Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific mRNA Vaccine Sales YoY Growth (2015-2026)
3.6 Europe mRNA Vaccine Market Size YoY Growth (2015-2026)
3.6.1 Europe mRNA Vaccine Revenue YoY Growth (2015-2026)
3.6.2 Europe mRNA Vaccine Sales YoY Growth (2015-2026)
3.7 Latin America mRNA Vaccine Market Size YoY Growth (2015-2026)
3.7.1 Latin America mRNA Vaccine Revenue YoY Growth (2015-2026)
3.7.2 Latin America mRNA Vaccine Sales YoY Growth (2015-2026)
3.8 Middle East and Africa mRNA Vaccine Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa mRNA Vaccine Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa mRNA Vaccine Sales YoY Growth (2015-2026) 4 Global mRNA Vaccine by Application
4.1 mRNA Vaccine Segment by Application
4.1.1 Infectious Disease
4.1.2 Cancer
4.1.3 Other
4.2 Global mRNA Vaccine Sales by Application: 2015 VS 2020 VS 2026
4.3 Global mRNA Vaccine Historic Sales by Application (2015-2020)
4.4 Global mRNA Vaccine Forecasted Sales by Application (2021-2026)
4.5 Key Regions mRNA Vaccine Market Size by Application
4.5.1 North America mRNA Vaccine by Application
4.5.2 Europe mRNA Vaccine by Application
4.5.3 Asia-Pacific mRNA Vaccine by Application
4.5.4 Latin America mRNA Vaccine by Application
4.5.5 Middle East and Africa mRNA Vaccine by Application 5 North America mRNA Vaccine Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America mRNA Vaccine Sales Market Share by Country (2015-2020)
5.1.2 North America mRNA Vaccine Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America mRNA Vaccine Sales Market Share by Country (2021-2026)
5.2.2 North America mRNA Vaccine Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. mRNA Vaccine Market Size YoY Growth (2015-2026)
5.3.2 Canada mRNA Vaccine Market Size YoY Growth (2015-2026) 6 Europe mRNA Vaccine Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe mRNA Vaccine Sales Market Share by Country (2015-2020)
6.1.2 Europe mRNA Vaccine Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe mRNA Vaccine Sales Market Share by Country (2021-2026)
6.2.2 Europe mRNA Vaccine Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany mRNA Vaccine Market Size YoY Growth (2015-2026)
6.3.2 France mRNA Vaccine Market Size YoY Growth (2015-2026)
6.3.3 U.K. mRNA Vaccine Market Size YoY Growth (2015-2026)
6.3.4 Italy mRNA Vaccine Market Size YoY Growth (2015-2026)
6.3.5 Russia mRNA Vaccine Market Size YoY Growth (2015-2026) 7 Asia-Pacific mRNA Vaccine Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific mRNA Vaccine Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific mRNA Vaccine Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific mRNA Vaccine Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific mRNA Vaccine Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.2 Japan mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.3 South Korea mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.4 India mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.5 Australia mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.6 Taiwan mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.7 Indonesia mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.8 Thailand mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.9 Malaysia mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.10 Philippines mRNA Vaccine Market Size YoY Growth (2015-2026)
7.3.11 Vietnam mRNA Vaccine Market Size YoY Growth (2015-2026) 8 Latin America mRNA Vaccine Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America mRNA Vaccine Sales Market Share by Country (2015-2020)
8.1.2 Latin America mRNA Vaccine Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America mRNA Vaccine Sales Market Share by Country (2021-2026)
8.2.2 Latin America mRNA Vaccine Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico mRNA Vaccine Market Size YoY Growth (2015-2026)
8.3.2 Brazil mRNA Vaccine Market Size YoY Growth (2015-2026)
8.3.3 Argentina mRNA Vaccine Market Size YoY Growth (2015-2026) 9 Middle East and Africa mRNA Vaccine Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa mRNA Vaccine Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa mRNA Vaccine Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa mRNA Vaccine Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa mRNA Vaccine Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey mRNA Vaccine Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia mRNA Vaccine Market Size YoY Growth (2015-2026)
9.3.3 U.A.E mRNA Vaccine Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in mRNA Vaccine Business
10.1 Moderna Therapeutics
10.1.1 Moderna Therapeutics Corporation Information
10.1.2 Moderna Therapeutics Description, Business Overview and Total Revenue
10.1.3 Moderna Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Moderna Therapeutics mRNA Vaccine Products Offered
10.1.5 Moderna Therapeutics Recent Development
10.2 CureVac
10.2.1 CureVac Corporation Information
10.2.2 CureVac Description, Business Overview and Total Revenue
10.2.3 CureVac mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.2.5 CureVac Recent Development
10.3 Translate Bio
10.3.1 Translate Bio Corporation Information
10.3.2 Translate Bio Description, Business Overview and Total Revenue
10.3.3 Translate Bio mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Translate Bio mRNA Vaccine Products Offered
10.3.5 Translate Bio Recent Development
10.4 BioNTech
10.4.1 BioNTech Corporation Information
10.4.2 BioNTech Description, Business Overview and Total Revenue
10.4.3 BioNTech mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.4.4 BioNTech mRNA Vaccine Products Offered
10.4.5 BioNTech Recent Development
10.5 Sangamo Therapeutics
10.5.1 Sangamo Therapeutics Corporation Information
10.5.2 Sangamo Therapeutics Description, Business Overview and Total Revenue
10.5.3 Sangamo Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Sangamo Therapeutics mRNA Vaccine Products Offered
10.5.5 Sangamo Therapeutics Recent Development
10.6 Argos Therapeutics
10.6.1 Argos Therapeutics Corporation Information
10.6.2 Argos Therapeutics Description, Business Overview and Total Revenue
10.6.3 Argos Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.6.4 Argos Therapeutics mRNA Vaccine Products Offered
10.6.5 Argos Therapeutics Recent Development
10.7 In-Cell-Art
10.7.1 In-Cell-Art Corporation Information
10.7.2 In-Cell-Art Description, Business Overview and Total Revenue
10.7.3 In-Cell-Art mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.7.4 In-Cell-Art mRNA Vaccine Products Offered
10.7.5 In-Cell-Art Recent Development
10.8 eTheRNA
10.8.1 eTheRNA Corporation Information
10.8.2 eTheRNA Description, Business Overview and Total Revenue
10.8.3 eTheRNA mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.8.4 eTheRNA mRNA Vaccine Products Offered
10.8.5 eTheRNA Recent Development
10.9 Ethris
10.9.1 Ethris Corporation Information
10.9.2 Ethris Description, Business Overview and Total Revenue
10.9.3 Ethris mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
10.9.4 Ethris mRNA Vaccine Products Offered
10.9.5 Ethris Recent Development
10.10 Tiba Biotechnology
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 mRNA Vaccine Product Category, Application and Specification
10.10.3 Tiba Biotechnology mRNA Vaccine Sales, Revenue, Price and Gross Margin (2015-2020)
10.10.4 Main Business Overview
10.10.5 Tiba Biotechnology Recent Development 11 mRNA Vaccine Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 mRNA Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 mRNA Vaccine Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Market Opportunities and Drivers
11.4.2 Market Challenges
11.4.3 Market Risks
11.4.4 Porter's Five Forces Analysis 12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA - 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mRNA Vaccine Market just Published Research Report here

News-ID: 2062765 • Views:

More Releases from QY Research, Inc

Global Metallized Film Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Metallized Film Industry Research Report, Growth Trends and Competitive A …
Metallized films are used both in packaging and industrial applications. Process of vacuum metallizing provides either decorative or barrier properties to plastic films. Metallized films are generally laminated to other films or paper. The global Metallized Film market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The United States market for Metallized
Global Isotridecyl Alcohol (ITDA) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Isotridecyl Alcohol (ITDA) Industry Research Report, Growth Trends and Co …
ITDA is a high-quality intermediate for the versatile and safe usage in the manufacturing of surfactants. The global Isotridecyl Alcohol (ITDA) market size was US$ 125.9 million in 2023 and is forecast to a readjusted size of US$ 172 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030. Isotridecyl Alcohol (ITDA)'s industry concentration degree is highly concentrated, only a few enterprises master the production technology, with the trend
Global β-Alanine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global β-Alanine Industry Research Report, Growth Trends and Competitive Analys …
Β-Alanine is a white powder, dissolved in water, soluble in methanol and ethanol, insoluble in ether and acetone. And it is a non-essential amino acid and is the only naturally occurring beta-amino acid. The global β-Alanine market size was US$ 19 million in 2023 and is forecast to a readjusted size of US$ 31 million by 2030 with a CAGR of 7.3% during the forecast period 2024-2030. Yifan Pharmaceutical is considered to
Global Fire Retarding Hydraulic Fluid Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Fire Retarding Hydraulic Fluid Industry Research Report, Growth Trends an …
Fire retarding hydraulic fluids are specially formulated lubricants that are more difficult to ignite and do not propagate a flame from an ignition source. The global Fire Retarding Hydraulic Fluid market size was US$ 1727.7 million in 2023 and is forecast to a readjusted size of US$ 2359.8 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030. Quaker Honghton gained the first place in the global fire retarding

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the